3kl6
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
| - | [[Image:3kl6. | + | [[Image:3kl6.png|left|200px]] |
<!-- | <!-- | ||
| Line 12: | Line 12: | ||
===Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally active factor Xa inhibitor=== | ===Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally active factor Xa inhibitor=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_20355714}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 20355714 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_20355714}} | ||
==Disease== | ==Disease== | ||
| Line 17: | Line 23: | ||
==About this Structure== | ==About this Structure== | ||
| - | 3KL6 is a 2 chains structure | + | 3KL6 is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3KL6 OCA]. |
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:20355714</ref><references group="xtra"/> | ||
[[Category: Coagulation factor Xa]] | [[Category: Coagulation factor Xa]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| Line 37: | Line 46: | ||
[[Category: Zymogen]] | [[Category: Zymogen]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu May 20 09:06:26 2010'' |
Revision as of 06:06, 20 May 2010
Contents |
Discovery of Tetrahydropyrimidin-2(1H)-one derivative TAK-442: A potent, selective and orally active factor Xa inhibitor
Template:ABSTRACT PUBMED 20355714
Disease
Known disease associated with this structure: Factor X deficiency OMIM:[227600]
About this Structure
3KL6 is a 2 chains structure with sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Fujimoto T, Imaeda Y, Konishi N, Hiroe K, Kawamura M, Textor GP, Aertgeerts K, Kubo K. Discovery of a tetrahydropyrimidin-2(1H)-one derivative (TAK-442) as a potent, selective, and orally active factor Xa inhibitor. J Med Chem. 2010 May 13;53(9):3517-31. PMID:20355714 doi:10.1021/jm901699j
Page seeded by OCA on Thu May 20 09:06:26 2010
Categories: Coagulation factor Xa | Homo sapiens | Aertgeerts, K. | Blood coagulation | Calcium | Cleavage on pair of basic residue | Coagulation factor xa | Disulfide bond | Egf-like domain | Gamma-carboxyglutamic acid | Glycoprotein | Hydrolase | Hydroxylation | Polymorphism | Protease | Secreted | Serine protease | Zymogen
